Mohamed‐Eslam F. Mohamed

Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

Mark C. Genovese, Roy Fleischmann, Bernard Combe et al. · The Lancet · 2018 · 415 citations

Rheumatoid Disorder, Rheumatology, Anti-inflammatory +9

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

Edward V. Loftus, Julián Panés, Ana P. Lacerda et al. · New England Journal of Medicine · 2023 · 373 citations · Full text

Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial

Emma Guttman‐Yassky, Diamant Thaçi, Aileen L. Pangan et al. · Journal of Allergy and Clinical Immunology · 2019 · 344 citations · Full text

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

William J. Sandborn, Brian G. Feagan, Edward V. Loftus et al. · Gastroenterology · 2020 · 302 citations · Full text

Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial

Ronald van Vollenhoven, Tsutomu Takeuchi, Aileen L. Pangan et al. · Arthritis & Rheumatology · 2020 · 216 citations · Full text